Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.422,80
0,13%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Bio Path Holdings Inc (BPTH) Bio Path Holdings Inc (BPTH) Notizie

BPTH

Bio Path (BPTH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPTH
DataOraFonteTitoloSimboloCompagnia
05/06/202423:46GlobeNewswire Inc.Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
05/06/202423:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BPTHBio Path Holdings Inc
04/06/202414:00GlobeNewswire Inc.Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
03/06/202413:00GlobeNewswire Inc.Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BPTHBio Path Holdings Inc
24/05/202413:00GlobeNewswire Inc.Bio-Path Holdings to Present Data at 2024 European Hematology Association CongressNASDAQ:BPTHBio Path Holdings Inc
23/05/202423:00GlobeNewswire Inc.Bio-Path Holdings to Present Data at American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:BPTHBio Path Holdings Inc
15/05/202413:50IH Market NewsU.S. Index Futures Flat Ahead of April CPI Data Release, Oil Prices DropNASDAQ:BPTHBio Path Holdings Inc
15/05/202413:00GlobeNewswire Inc.Bio-Path Holdings Reports First Quarter 2024 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
14/05/202422:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BPTHBio Path Holdings Inc
08/05/202413:00GlobeNewswire Inc.Bio-Path Holdings to Announce First Quarter 2024 Financial Results on May 15, 2024NASDAQ:BPTHBio Path Holdings Inc
19/04/202418:14GlobeNewswire Inc.Bio-Path Holdings, Inc. Announces Closing of $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
18/04/202419:57GlobeNewswire Inc.Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BPTHBio Path Holdings Inc
18/04/202413:00GlobeNewswire Inc.Bio-Path Holdings Announces Successful Completion of Higher Dose Second Cohort in Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid Leukemia (AML) PatientsNASDAQ:BPTHBio Path Holdings Inc
15/04/202413:00GlobeNewswire Inc.Bio-Path Holdings Expands Global Patent PortfolioNASDAQ:BPTHBio Path Holdings Inc
02/04/202413:00GlobeNewswire Inc.Bio-Path Holdings Provides 2024 Clinical and Operational UpdateNASDAQ:BPTHBio Path Holdings Inc
08/03/202423:11Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BPTHBio Path Holdings Inc
08/03/202413:00GlobeNewswire Inc.Bio-Path Holdings Reports Full Year 2023 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
08/03/202412:22IH Market NewsU.S. Index Futures Fluctuate Ahead of Key Jobs Report; Oil Prices DipNASDAQ:BPTHBio Path Holdings Inc
07/03/202422:21Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BPTHBio Path Holdings Inc
01/03/202413:00GlobeNewswire Inc.Bio-Path Holdings to Announce Fourth Quarter and Full Year 2023 Financial Results on March 8, 2024NASDAQ:BPTHBio Path Holdings Inc
29/02/202412:00Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:BPTHBio Path Holdings Inc
21/02/202413:00GlobeNewswire Inc.Bio-Path Holdings Announces 1-for-20 Reverse Stock SplitNASDAQ:BPTHBio Path Holdings Inc
02/02/202422:39Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BPTHBio Path Holdings Inc
23/01/202422:51Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BPTHBio Path Holdings Inc
17/01/202422:52Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:BPTHBio Path Holdings Inc
10/01/202413:00GlobeNewswire Inc.Bio-Path Holdings Announces Completion of First Dose Cohort in Phase 1 Clinical Trial Evaluating BP1002 to Treat Refractory/Relapsed Lymphoma and Refractory/Relapsed Chronic Lymphocytic Leukemia PatientsNASDAQ:BPTHBio Path Holdings Inc
04/01/202423:18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:BPTHBio Path Holdings Inc
22/12/202322:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BPTHBio Path Holdings Inc
14/12/202313:00GlobeNewswire Inc.Bio-Path Holdings Successfully Completes First Dose Cohort of Phase 1/1b Clinical Trial of BP1002 in Refractory/Relapsed Acute Myeloid LeukemiaNASDAQ:BPTHBio Path Holdings Inc
15/11/202313:00GlobeNewswire Inc.Bio-Path Holdings Reports Third Quarter 2023 Financial ResultsNASDAQ:BPTHBio Path Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:BPTH

La tua Cronologia

NASDAQ
PYMNX
PIMCO High Yield Municip...
BOV
TPIS3
TRIUNFO PART ON
COIN
NUTSUSD
Squirrel Finance
COIN
NUTSETH
Squirrel Finance
AQSE
SJPA.GB
MSCI Japan IMI UCITS ETF
BOV
DOHL4Q
DOHLER PN
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network